Research & Ideas
OCTOBER 27, 2020
UC Berkeley institute to end COVID-19 saliva test trial
UC Berkeley's Innovative Genomics Institute, or IGI's, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board